Works matching IS 09596658 AND DT 2018 AND VI 28 AND IP 9
Results: 7
Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 640, doi. 10.1093/glycob/cwx108
- By:
- Publication type:
- Article
Selectins in cancer immunity.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 648, doi. 10.1093/glycob/cwx105
- By:
- Publication type:
- Article
Meeting and Course Announcements.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 637, doi. 10.1093/glycob/cwy073
- Publication type:
- Article
Glycan-directed CAR-T cells.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 656, doi. 10.1093/glycob/cwy008
- By:
- Publication type:
- Article
Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 697, doi. 10.1093/glycob/cwy043
- By:
- Publication type:
- Article
Cancer Immunotherapy.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 638, doi. 10.1093/glycob/cwy069
- By:
- Publication type:
- Article
Cancer glycan epitopes: biosynthesis, structure and function.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 670, doi. 10.1093/glycob/cwy023
- By:
- Publication type:
- Article